Name | Title | Contact Details |
---|---|---|
Shalom Shushan |
Chief Technology Officer | Profile |
Micropulse, Inc., located 30 miles east of the Orthopaedic Capital of the World, has been serving the Medical Device Industry as a manufacturer of orthopaedic instruments and implants since 1988. Although Micropulse was founded as a precision tooling
Smith & Nephew is a global advanced medical technology business. We support healthcare professionals in more than 100 countries to improve the quality of life for their patients. Since 1856, when our founder T.J. Smith developed a new method for refining cod liver oil, and in World War One when his nephew led the supply of wound care products, to the present day, Smith & Nephew continues to pioneer health solutions. Through our market leadership positions in Sports Medicine, Trauma, Orthopaedic Reconstruction and Advanced Wound Management, our 16,000 employees continue to improve outcomes and expand access, constantly striving to create value for healthcare professionals, patients, payers and shareholders. Annual sales in 2016 were more than $4.6 billion. We are a constituent of the UK’s FTSE100 and our shares are traded on London Stock Exchange and through American Depository Receipts on the New York Stock Exchange We have leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma. We have almost 11,000 employees and a presence in more than 90 countries. Annual sales in 2013 were more than $4.3 billion. We are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN)
Founded in 2006, Ocular Therapeutix is a fast-growing, aspiring leader in the biopharmaceutical industry. The company has a clear vision – to improve current therapeutic options in ophthalmology by encapsulating previously approved therapeutic agents in our novel hydrogel to provide a sustained delivery of drugs to the eye. We are reframing the industry with new modalities for ophthalmic therapies. As a small company, our employees are provided the unique opportunity to help build the foundation of the business as it grows. We strongly believe that our success is contingent upon the achievements of our employees. We strive to create a collaborative, challenging environment that encourages individuals to bring success to their career and the company. Through the use of our proprietary hydrogel technology, we strive to offer superior products that improve the world’s vision.
Forzzi Optical L.C. is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Chattanooga Canada Inc. is a Vaudreuil-Dorion, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.